14.03.2016 • NewsoperationsManufacturingBiosuccinium

Ad Smolders Joins Reverdia As Operations Director

Reverdia has announced that Ad Smolders has joined the company as Operations...
Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Smolders previously worked at DSM for seventeen years in various international technology and manufacturing assignments. More recently, he has overseen an extensive number of operations projects, including the optimization of yeast plants, as a consultant and interim manager.

Marcel Lubben, Reverdia’s President said, “With his considerable experience in manufacturing and process improvement, Ad Smolders will lead Reverdia’s operations to the next stage of growth.  His leadership in manufacturing excellence will further bolster our low pH yeast technology. This will benefit both our clients out of Cassano and also our partners and licensees for future Biosuccinium plants.”   
 
 

Company

Reverdia

Urmonderbaan 20H
6167 RD Geleen

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.